index - Myopathies inflammatoires & thérapies innovantes ciblées Accéder directement au contenu

Dernières publications

Chiffres clés

123 Publications avec texte intégral

Open Access

53 %

Mots clés

Acute Kidney Injury/epidemiology/etiology Adeno-associated virus Polymyositis Amyotrophic lateral sclerosis Cytokines Amyotrophy Sphingosine-1-phosphate IMNM Antibodies Dependovirus/genetics/immunology Adeno-associated vector Anticorps anti-agalsidase Inflammation Biomarkers Aged Anémie hémolytique Immune checkpoint inhibitors Active Adverse drug reactions Case reports Agalsidase Idiopathic inflammatory myopathies AAV Prognosis Muscle Antisynthetase syndrome Myopathy Interstitial lung disease Assisted communication devices Anti-agalsidase antibodies Machine learning Arthritis Male Myositis Dermatomyositis Abnormal movement Biomarqueurs Acid-alpha-glucosidase Lysosomal storage diseases Pharmacology Middle Aged Anti-interleukin-6 Antiphospholipid syndrome Adeno-associated virus vector Anticorps spécifique des myosites Female Analyses multidimensionnelles Aldosterone Autoimmunity Skeletal muscle Adult B-lymphocyte Mass cytometry Inflammatory myopathy Autoimmune diseases Autoantibody Aldostérone Anti-IgE IgG Anti‐mitochondrial antibodies Gene therapy COVID-19 IBM Systems biology DM Animals Adolescence Anti-drug antibodies Outcome measures AAV vectors Fabry disease Cancer Anti-Mi2 Auto-antibodies Data integration AAV antibody Biopsy AAV vector Myositis and muscle disease Autoantibodies Cardio-oncology Antisynthétase Auto-immunité Humans Inclusion body myositis B cell homeostasis AAV humoral immunity Anti-MDA5 autoantibodies Antisynthetase Multidisciplinarity Inborn errors of metabolism Biomarker Anti-synthetase syndrome Bioelectrical impedance analysis Auto‐antibodies Myocarditis Interferon Deep immune profiling Adjudication Antibody responses Immunotherapy